Companies → RANBAXY (S A) (PTY) LTD
RANBAXY (S A) (PTY) LTD
South Africa, Gauteng, Centurion
Updated Jul 8, 2024 15:36
Description
Sun Pharma is a specialty generic pharmaceutical company engaged in developing, manufacturing, and marketing a large basket of specialty generic pharmaceutical products. The Company's global presence extends across 63 countries. The Company's portfolio constitutes, but is not limited to CNS (Central Nervous System), cardiovascular, gastrointestinal, anti-infectives, diabetes, ophthalmology, respiratory, dermatology, pain management, urology, and oncology segments. The Company covers all major therapeutic areas and has a significant presence across key emerging markets in South America, Eastern Europe, Asia, and Africa. The Company also provides a range of treatments for complex and chronic diseases. In South Africa, the Company offers a wide variety of treatments for various medical conditions. They are committed to providing high-quality, effective, and affordable medicines to patients worldwide.
Industries
Address:
GROUND FLOOR TUGELA HSE
RIVERSIDE OFFICE PARK 1303 HEUWEL AV CE CENTURION
Gauteng
0046 South Africa
Website:
Revenue
$40.28M
Company is likely to buy
- Medical packaging materials (including vials, bottles, ampoules, blisters, and labels)
- Active pharmaceutical ingredients and excipients
- Medical devices (including syringes, needles, catheters, and implants)
- Medical equipment (including diagnostic imaging systems, surgical instruments, and patient monitoring devices)
- Laboratory equipment and supplies (including microscopes, centrifuges, and reagents)
- Chemicals for pharmaceutical manufacturing (including solvents, reaction media, and catalysts)
- Biotechnology products (including vaccines, monoclonal antibodies, and gene therapies)
- Packaging and labeling machinery
- Warehouse and distribution services
- Transportation and logistics services
- Marketing and advertising services
- Clinical trial management services
- Regulatory compliance services
- Quality control and assurance services
- Research and development services
- Information technology services
- Cloud computing services
- Data analytics services
- Artificial intelligence services
- Machine learning services
- Blockchain technology services
- Medical education and training services
- Patient support services
- Managed care services
- Pharmacovigilance services
- Healthcare consulting services
- Medical writing services
- Translation services
- Market research services
Company is likely to sell
- Formaldehyde
- Mannitol
- Erythritol
- Sorbitol
- Glycerin
- Xylitol
- Pyridoxine hydrochloride (vitamin b6), non-medicinal
- Ascorbic acid (vitamin c)
- Nislt (nonionic surfactant)
- Pva (polyvinyl alcohol)
- Pvp k30 (polyvinylpyrrolidone)
- Peg 400 (polyethylene glycol)
- Talc
- Iron oxide (yellow)
- Titanium dioxide
- D&c yellow no.10
- D&c red no.27
- Fd&c blue no.1
- Fd&c red no.40
- Methylparaben
- Butylparaben
- Sodium benzoate
- Potassium sorbate
- Sodium metabisulfite
- Bha (butylated hydroxyanisole)
- Bht (butylated hydroxytoluene)
- Polyoxyethylene (20) sorbitan monolaurate (tween 20)
- Sucralose (artificial sweetener)
- Isomaltulose
- Carrageenan
Disclaimer:
IndexBox is not affiliated with, associated with, or endorsed by this company in any way. The information provided on this page, including company details, is solely for informational purposes. IndexBox makes no representations or warranties about the accuracy or completeness of the information provided.